Associated Papers
Exome sequencing reveals new insights into the germline landscape of inflammatory breast cancer among Tunisian patients.
Boujemaa M et al.
Journal of Translational Medicine, 2025
41088366 (PubMed )
Supplement: 12967_2025_7027_MOESM1_ESM.xlsx › S5
Leveraging Human Genetics to Identify Safety Signals Prior to Drug Marketing Approval and Clinical Use.
Jerome RN et al.
Drug Safety, 2020
Accelerating Precision Drug Development and Drug Repurposing by Leveraging Human Genetics.
Pulley JM et al.
Assay and Drug Development Technologies, 2017
c.G2114A MYH9 mutation (DFNA17) causes non-syndromic autosomal dominant hearing loss in a Brazilian family.
Dantas VG et al.
Genetics and Molecular Biology, 2014
Targeted high-throughput sequencing identifies mutations in atlastin-1 as a cause of hereditary sensory neuropathy type I.
Guelly C et al.
American Journal of Human Genetics, 2011
Select a paper to view details